The mechanism described in our studies for the degradation of HIF1A by CMA, as well as other alternative mechanism described for HIF1A proteolysis, are likely to impact on a variety of pathophysiological conditions where cells are submitted to prolonged hypoxia (e.g. solid tumor growth, diabetic retinopathy, cardiac infarction). The gene discussed is HIF1A; the disease is diabetic retinopathy.